QTTB Q32 Bio Inc.
Research report · from SEC EDGAR · close 2026-07-13
$21.38 +90.7%
$362.5M mkt cap
executive summary
Q32 Bio Inc. (QTTB) is a $362.5M company. Revenue is $53.7M at a 55% net margin. It is profitable. Our health score is C (56/100). 2 red flags on file. Smart money is buying (2 insider). It may need to raise cash (dilution risk).
⛔Going-concern warning
Auditor flagged substantial doubt about the company continuing for the next 12 months — a raise is usually required.
⚠Active dilution shelf
An effective S-3 shelf with 4 prospectus filing(s) in 12 months — shares may be getting sold into the market.
who's buying
Insider buys / sells
2 / 3
Cash & ST investments
$50.8M
Operating cash flow
-$33.5M
Dilution shelf
active shelf
FILINGReg FD disclosure
8-K filed 2026-07-13
FILINGOther events
8-K filed 2026-07-13
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.